News Home

Do Analysts Expect Ginkgo Bioworks Holdings Inc (DNA) Stock to Rise After It Has Fallen -24.07% in a Month?

Wednesday, September 07, 2022 10:15 AM | InvestorsObserver Analysts
Do Analysts Expect Ginkgo Bioworks Holdings Inc (DNA) Stock to Rise After It Has Fallen -24.07% in a Month?

Analysts who follow Ginkgo Bioworks Holdings Inc (DNA) on average expect it to add 282.85% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns DNA an Analyst Ranking of 40, which means it ranks higher than 40 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 4.1
Wall Street analysts are rating DNA a Strong Buy today. Find out what this means to you and get the rest of the rankings on DNA!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Ginkgo Bioworks Holdings Inc Stock Today?

Ginkgo Bioworks Holdings Inc (DNA) stock is trading at $2.46 as of 10:08 AM on Wednesday, Sep 7, a rise of $0.05, or 1.86% from the previous closing price of $2.42. The stock has traded between $2.40 and $2.52 so far today. Volume today is light. So far 1,870,314 shares have traded compared to average volume of 29,078,406 shares. Click Here to get the full Stock Report for Ginkgo Bioworks Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App